AR9.AX

AR9.AX has a market price of 0.072 AUD and a market cap of 34.77 million AUD, indicating a small-cap profile. The company's price-to-book ratio is 6.44, and its price-to-tangible-book ratio is also 6.44, suggesting that the market is valuing the company's equity at a premium relative to its book value. The enterprise value to EBITDA ratio is negative at -7.24, reflecting the company's current unprofitability. The enterprise value to revenue ratio is 6.03, which is a measure of the company's revenue-based valuation. In terms of profitability, AR9.AX reported a net income of -4.76 million AUD and an operating income of -5.10 million AUD, indicating a significant loss. The return on equity is -0.88, and the return on assets is -0.28, both of which are negative, suggesting poor capital efficiency and asset utilization. The company's gross profit is 4.70 million AUD, but this is not sufficient to cover its operating expenses. The debt-to-equity ratio is 0.4, indicating a relatively low level of leverage, and the current ratio is 0.61, suggesting potential liquidity constraints. AR9.AX's revenue is concentrated in a single segment, as disclosed in its financial statements. The company's geographic exposure is not explicitly detailed, but the financial data suggests a primary focus on the Australian market. The company's revenue concentration and geographic exposure may pose risks if market conditions in the region deteriorate. The company's growth trajectory is uncertain, as it has reported a net loss in the current fiscal year. The operating cash flow is positive at 2.96 million AUD, but the free cash flow is negative at -3.49 million AUD, indicating that the company is not generating sufficient cash to fund its operations and capital expenditures. The capital expenditure of -3.00 million AUD suggests that the company is investing in its operations, but the negative free cash flow indicates that these investments are not yet generating positive returns. The risk assessment for AR9.AX indicates a medium level of liquidity risk and a low level of dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which may impact its ability to meet short-term obligations. The dilution risk is low, but the company's negative free cash flow and high price-to-book ratio may indicate potential for future dilution if the company needs to raise additional capital. Recent events and filings for AR9.AX include analyst estimates that suggest a mean price target of 0.35 AUD, with a median and high price target also at 0.35 AUD. The mean recommendation from analysts is 2.00, indicating a "buy" rating, with one "buy" recommendation and no "strong buy" or "hold" recommendations. These analyst estimates suggest a positive outlook for the company, but the current financial performance does not support this optimism.